• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Q-MED AB DUROLANE; HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Q-MED AB DUROLANE; HYALURONIC ACID Back to Search Results
Model Number N/A
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Necrosis (1971)
Event Date 01/25/2021
Event Type  Injury  
Event Description
A woman in her 60s with a medical history of osteoarthritis presented with a one-week history of a mildly pruritic and tender lesion on the left lateral knee.The patient had received a hyaluronic acid injection one month prior to the same knee for osteoarthritis.The patient noticed worsened symptoms in cold temperatures or with pressure.Physical examination revealed a 9 cm x 8 cm erythematous to violaceous reticular, partially blanchable patch on the left lateral knee (figure 1).On examination, the patient was well-appearing and afebrile.A punch biopsy was performed (figure 2, 3).Microscopic examination showed epidermal necrosis (figure 2) and bluish material, consistent with hyaluronic acid, occluding vessels in the dermis (figure 3, 4).A diagnosis of hyaluronic acid embolus was rendered.The patient was given 130 units of hyaluronidase injected into the left lateral knee.Immediate improvement of pain and discoloration was observed.Subsequent 150 and 300 units of hyaluronidase were injected at 60-minute intervals.The patient was advised to continue massaging and elevating leg with the goal of decreasing remaining erythema.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE
Type of Device
HYALURONIC ACID
Manufacturer (Section D)
Q-MED AB
seminariegatan 21
uppsala, SE-75 2 28
SW  SE-752 28
MDR Report Key15702946
MDR Text Key302760128
Report Number3009595577-2022-00003
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 10/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/31/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number1082020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/06/2022
Event Location Hospital
Date Report to Manufacturer10/06/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexFemale
-
-